Celine J. Marmion

2.1k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Celine J. Marmion is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Celine J. Marmion has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Organic Chemistry and 13 papers in Molecular Biology. Recurrent topics in Celine J. Marmion's work include Metal complexes synthesis and properties (18 papers), Ferrocene Chemistry and Applications (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Celine J. Marmion is often cited by papers focused on Metal complexes synthesis and properties (18 papers), Ferrocene Chemistry and Applications (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). Celine J. Marmion collaborates with scholars based in Ireland, Singapore and Russia. Celine J. Marmion's co-authors include Darren M. Griffith, Kevin B. Nolan, Maria P. Morgan, Kyrill Yu. Suponitsky, James R. Docherty, Brendan Twamley, Etelka Farkas, Deirdre Fitzgerald‐Hughes, Isolda Romero‐Canelón and Kevin Kavanagh and has published in prestigious journals such as Chemical Reviews, Chemical Communications and Coordination Chemistry Reviews.

In The Last Decade

Celine J. Marmion

41 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?

2019 529 citations Celine J. Marmion et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Celine J. Marmion Ireland	22	1.1k	960	546	331	297	42	1.8k
Tiziano Marzo Italy	32	1.3k 1.2×	1.1k 1.2×	704 1.3×	257 0.8×	378 1.3×	100	2.3k
Maria V. Babak Hong Kong	23	1.3k 1.2×	1.2k 1.2×	490 0.9×	314 0.9×	336 1.1×	64	2.2k
Shaohua Gou China	31	1.2k 1.1×	1.2k 1.2×	663 1.2×	249 0.8×	430 1.4×	115	2.3k
Jose M. Pérez Spain	20	1.4k 1.3×	1.1k 1.2×	564 1.0×	216 0.7×	288 1.0×	40	2.0k
Ahmed M. Mansour Egypt	27	1.1k 0.9×	1.2k 1.2×	671 1.2×	288 0.9×	331 1.1×	130	2.4k
I. Bratsos Italy	21	1.2k 1.1×	1.0k 1.0×	388 0.7×	384 1.2×	431 1.5×	36	1.8k
Orsolya Dömötör Hungary	23	930 0.8×	635 0.7×	424 0.8×	283 0.9×	282 0.9×	56	1.3k
Robert Trondl Austria	14	1.1k 1.0×	876 0.9×	334 0.6×	296 0.9×	192 0.6×	15	1.5k
Lara Massai Italy	26	1.0k 0.9×	847 0.9×	625 1.1×	156 0.5×	296 1.0×	88	1.9k
N. Cutillas Spain	22	880 0.8×	1.0k 1.1×	223 0.4×	263 0.8×	280 0.9×	41	1.5k

Countries citing papers authored by Celine J. Marmion

Since Specialization

Citations

This map shows the geographic impact of Celine J. Marmion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celine J. Marmion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celine J. Marmion more than expected).

Fields of papers citing papers by Celine J. Marmion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celine J. Marmion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celine J. Marmion. The network helps show where Celine J. Marmion may publish in the future.

Co-authorship network of co-authors of Celine J. Marmion

This figure shows the co-authorship network connecting the top 25 collaborators of Celine J. Marmion. A scholar is included among the top collaborators of Celine J. Marmion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celine J. Marmion. Celine J. Marmion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Previtali, Viola, et al.. (2025). Platinum(ii) complexes of aryl guanidine-like derivatives as potential anticancer agents: between coordination and cyclometallation. RSC Advances. 15(5). 3427–3438. 1 indexed citations

Ding, Wei, Xinxin Shao, Xiaofei Yin, et al.. (2023). Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer. Cellular Oncology. 47(2). 533–553. 3 indexed citations

Sheehan, Gerard, et al.. (2021). Multi-targeted metallo-ciprofloxacin derivatives rationally designed and developed to overcome antimicrobial resistance. International Journal of Antimicrobial Agents. 58(6). 106449–106449. 9 indexed citations

Docherty, James R., et al.. (2019). Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors. Journal of Inorganic Biochemistry. 206. 110981–110981. 22 indexed citations

Marmion, Celine J., et al.. (2016). Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?. European Journal of Inorganic Chemistry. 2017(12). 1596–1612. 134 indexed citations

Romero‐Canelón, Isolda, et al.. (2016). A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — Anti-proliferative and anti-microbial activity. Journal of Inorganic Biochemistry. 160. 210–217. 63 indexed citations

Nimir, Hassan, Darren M. Griffith, Brian Duff, et al.. (2013). A novel platinum complex of the histone deacetylase inhibitor belinostat: Rational design, development and in vitro cytotoxicity. Journal of Inorganic Biochemistry. 124. 70–77. 28 indexed citations

Griffith, Darren M., et al.. (2011). Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes. Journal of Inorganic Biochemistry. 105(6). 763–769. 76 indexed citations

Griffith, Darren M., Brian Duff, Kyrill Yu. Suponitsky, et al.. (2011). Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity. Journal of Inorganic Biochemistry. 105(6). 793–799. 41 indexed citations

10.

Griffith, Darren M., et al.. (2010). Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry. 10(5). 354–370. 45 indexed citations

11.

Griffith, Darren M., Maria P. Morgan, & Celine J. Marmion. (2009). A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. Chemical Communications. 6735–6735. 97 indexed citations

12.

Griffith, Darren M., Sara Cecco, Ennio Zangrando, et al.. (2008). Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation. JBIC Journal of Biological Inorganic Chemistry. 13(4). 511–520. 32 indexed citations

13.

Griffith, Darren M., et al.. (2007). Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium(iii) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigation. Dalton Transactions. 137–147. 32 indexed citations

14.

Dolgushin, F.M., et al.. (2005). Synthesis, characterisation and speciation studies of heterobimetallic pyridinehydroxamate-bridged Pt(ii)/M(ii) complexes (M = Cu, Ni, Zn). Crystal structure of a novel heterobimetallic 3-pyridinehydroxamate-bridged Pt(ii)/Cu(ii) wave-like coordination polymer. Dalton Transactions. 1993–1993. 20 indexed citations

15.

Griffith, Darren M., Konstantin А. Lyssenko, Paul R. Jensen, Paul E. Kruger, & Celine J. Marmion. (2005). Novel platinum(ii) ammine hydroxamate and hydroximate complexes and the platinum-assisted hydrolysis of hydroxamic acids. Dalton Transactions. 956–956. 28 indexed citations

16.

Marmion, Celine J., et al.. (2004). Ruthenium as an Effective Nitric Oxide Scavenger. Current Topics in Medicinal Chemistry. 4(15). 1585–1603. 23 indexed citations

17.

Marmion, Celine J., Darren M. Griffith, & Kevin B. Nolan. (2004). Hydroxamic Acids — An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands. ChemInform. 35(40). 1 indexed citations

18.

Griffith, Darren M., Ennio Zangrando, Enzo Alessio, & Celine J. Marmion. (2004). A novel ruthenium nitrosyl complex which also contains a free NO-donor moiety. Inorganica Chimica Acta. 357(12). 3770–3774. 10 indexed citations

19.

Marmion, Celine J., et al.. (2001). Ruthenium(iii) readily abstracts NO from l-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthases. Chemical Communications. 1870–1871. 15 indexed citations

20.

Hughes, David L., Leslie F. Larkworthy, G.J. Leigh, et al.. (1997). New tetradentate Schiff bases, their oxovanadium(IV) complexes, and some complexes of bidentate Schiff bases with vanadium(III). Polyhedron. 16(9). 1517–1528. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact